Delivering expert imaging analysis by doctors utilizing better than human AI software with industry leading data management to support global clinical trials.
SPECIALISATION IN:
- Amyloidosis (ATTR-CM)
- Fabry’s
- Cardiomyopathies
(HCM, DCM, ARVC)
- Inflammatory Cardiomyopathies
- Heart Failure
(HFrEF, HFpEF) - Myocarditis
- Aortic Stenosis
- Cardio-Oncology
- Cell/Gene Therapies
At MyCardium AI, we combine innovation and expertise to revolutionize cardiac imaging. From cutting-edge AI solutions like 1CMR Pro and EchoConfidence to expert Core Lab services, we’re advancing heart health with precision and efficiency.
PARTNERSHIPS
Latest News & Updates
Echo Confidence Receives FDA 510(K) Clearance
EchoConfidence Receives FDA 510(k) Clearance We’re thrilled to share a major milestone at MyCardium AI, our AI-powered echocardiography platform, EchoConfidence, has officially received FDA 510(k) clearance! This clearance not only confirms the safety and effectiveness of EchoConfidence, but i....
MyCardium AI at BCS 2025: Empowering the Future of CMR Training
We were proud to sponsor this year’s British Cardiovascular Society (BCS) Annual Conference, where clinical education and cutting-edge technology came together to shape the future of cardiac imaging. As part of our commitment to advancing cardiovascular care, we showcased 1CMR Pro, our AI-powered ....
MyCardium AI Joins AXREM, Strengthening Commitment to UK Healthcare Innovat...
Liverpool, UK – MyCardium AI, a pioneering Healthtech company developing cutting edge AI solutions for cardiac imaging, is proud to announce that it is now an official member of AXREM, the UK trade association representing the medical imaging and radiotherapy industry. By joining AXREM, MyCardi....
Contact
E: info@mycardium.com
T: +44 (0)151 230 2116
The Spine Building, 2 Paddington Village, Liverpool Merseyside, England, L7 3FA
Further Contact Options >
©2025 MyCardium AI
Website design by Modern Websites
